| Phase 13 trials |
|
Phase 1
|
NCT03434977 |
Feb → Mar 2018 |
— |
Takeda |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT03042299 |
Feb → Mar 2017 |
— |
Takeda |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT02786082 |
Nov 2016 → Aug 2017 |
hypertensive disorder |
Lee's Pharmaceutical Limited |
Completed
|
No outcome recorded
|
| Phase 23 trials |
|
Phase 2
|
NCT01289132 |
Jul 2007 → Jul 2008 |
essential hypertension |
Takeda |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00759551 |
Aug 2004 → Jun 2005 |
essential hypertension |
Takeda |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00762736 |
Jul 2004 → Oct 2005 |
type 2 diabetes mellitus |
Takeda |
Completed
|
No outcome recorded
|
| Phase 39 trials |
|
Phase 3
|
NCT04668157 |
May 2021 → Dec 2023 |
hypertensive disorder |
Takeda |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT04606563 |
Oct 2020 → Apr 2022 |
COVID-19 |
University of British Columbia |
Terminated
|
No outcome recorded
|
|
Phase 3
|
NCT02791438 |
Aug 2016 → Jun 2019 |
early onset hypertension |
Takeda |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT02609490 |
Sep 2015 → Feb 2017 |
essential hypertension |
Lee's Pharmaceutical Limited |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT02451150 |
Aug → Sep 2015 |
early onset hypertension |
Takeda |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT02407210 |
Jan → Oct 2015 |
essential hypertension |
Jiangsu HengRui Medicine Co., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 3
|
NCT02277691 |
Nov 2014 → Apr 2016 |
essential hypertension |
Takeda |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT01124656 |
Sep 2006 → May 2007 |
type 2 diabetes mellitus |
Takeda |
Terminated
|
No outcome recorded
|
|
Phase 3
|
NCT00376181 |
Jun 2006 → May 2007 |
type 2 diabetes mellitus |
Takeda |
Terminated
|
No outcome recorded
|
| Phase 43 trials |
|
Phase 4
|
NCT05841654 |
Jun 2023 → Jun 2025 |
atrial fibrillation, hypertensive disorder |
Beijing Tsinghua Chang Gung Hospital |
Unknown
|
No outcome recorded
|
|
Phase 4
|
NCT02400775 |
Mar 2015 → Apr 2016 |
— |
Takeda |
Withdrawn
|
No outcome recorded
|
|
Phase 4
|
NCT02079805 |
Jun 2014 → Apr 2016 |
type 2 diabetes mellitus |
Takeda |
Completed
|
No outcome recorded
|
| Phase not applicable2 trials |
| — |
NCT05753696 |
Apr 2023 → Oct 2024 |
diabetic kidney disease, hypertensive disorder, impaired renal function disease, proteinuria |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
Unknown
|
No outcome recorded
|
| — |
NCT01762501 |
Dec 2012 → Dec 2013 |
essential hypertension |
Sogo Rinsho Médéfi Co., Ltd. |
Completed
|
No outcome recorded
|